StandUPTV Habits: Feasibility Trial for Maintaining Reductions in Sedentary Screen Time

Not Applicable

Not yet recruiting

• Conditions: Sedentary Behaviors; Screen Time; Physical Activity; Glucose Metabolism; Sleep Quality; HbA1c Level

• Registration Number: NCT06700525
• Lead Sponsor: Arizona State University

Brief Summary

Our goal in this study is to further refine StandUPTV, an application designed to reduce SST in adults in our first study (ASU IRB # STUDY00012109), for the StandUPTV Habits program. This program aims to establish a non-sedentary habit triggered by an alert from the StandUPTV application after participants engage in approximately 30 minutes of SST in the evening.

Detailed Description

This mobile health (mHealth) pilot study aims to develop and test an intervention designed to maintain reductions in evening sedentary screen time (eSST) over a 12-month period. The study will target a nationally recruited sample of adults at risk for type 2 diabetes and will employ a novel habit formation strategy to address individual barriers to sustained behavior change. As a Phase II pilot study within the ORBIT Model framework, this research seeks to provide critical insights into the relationship between maintained reductions in eSST and metabolic health. The intervention combines theory- and evidence-based approaches, leveraging commercially available screen time monitoring tools to scale the StandUPTV application. This pilot study will lay the groundwork for a subsequent Phase III fully-powered randomized clinical trial, aiming to evaluate the impact of sustained eSST reduction on diabetes and cardiovascular disease risk in a national sample.

Study Timeline

• Study First Submitted: 2024-11-20
• Study First Submitted QC: 2024-11-20
• Study First Posted: 2024-11-22
• Status Verified: 2025-04
• Last Update Submitted: 2025-04-02
• Last Update Posted: 2025-04-04
• Study Start: 2025-05-01
• Primary Completion: 2026-04-30
• Study Completion: 2027-12-31

Recruitment & Eligibility

• Status: NOT_YET_RECRUITING
• Sex: All
• Target Recruitment: 48

Inclusion Criteria

• Insufficiently active as defined by not meeting current US National Guidelines for Physical Activity of 150 minutes of MVPA/week (Measured by the Stanford
• Leisure-Time Activity Categorical Item)
• > 3 hours of SST per day
• Use Android (8.0+) smartphone (8.0+ represents 95% of Android device coverage per https://apilevels.com/)
• Have regular broadband internet in their home or an unlimited data plan
• Able to read/understand English (>5th grade literacy)
• Willing to download StandUPTV Habits
• Willing to wear activPAL and CGM device during study assessment periods
• Willing to have data shared in de-identified form in Dexcom Clarity platform
• Willing to be randomized to either study condition
• Not traveling overnight or longer in the next 4 months

Exclusion Criteria

• Planned relocation
• Current smoker
• Have a major illness (e.g., heart disease, cancer, renal disease) for which MVPA is contraindicated
• Diagnosed with diabetes or gestational diabetes in the past
• Currently using a CGM
• Pregnant
• Occupation that requires substantial use of personal device for media-related activities (e.g., social media)
• Drug abuse
• Serious psychological disorder
• Not willing to use Fitbit or smart plugs for calculation of sedentary screen time for functionality of StandUPTV app

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Changes in Sedentary Screen Time	Baseline, 4 months, 12 months	Minutes per week as measured by Stand UPTV app and activPAL

Secondary Outcome Measures

Name	Time	Method
Changes in moderate to vigorous physical activity	Baseline, 4 months, 12 months	Minutes per week as measured by activPAL
Changes in Sleep Quality	Baseline, 4 months, 12 months	Measured in minutes of deep sleep
Changes in Glucose Metabolism	Baseline, 4 months, 12 months	Measured HbA1c levels
HbA1c Level	Baseline, 4 months, 12 months	Participants continuous glucose monitoring data will be used to estimates HbA1c levels

Trial Locations

Locations (2)

Arizona State University; 🇺🇸 Tempe, Arizona, United States

California Polytechnic University San Luis Obispo; 🇺🇸 San Luis Obispo, California, United States